≡ Risteys
R13

Documentation Changelog GitHub Contact & Feedback

Deaf mutism, not elsewhere classified

EFO MESH Endpoint Browser PheWeb

H8_HL_DEAFMUT

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519972

1. Apply sex-specific rule

None

519972

2. Check conditions

None

519972

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — H91.3
  • Hospital discharge: ICD-9 — 3897
  • Hospital discharge: ICD-8 — 388
  • Cause of death: ICD-10 — H91.3
  • Cause of death: ICD-9 — 3897
  • Cause of death: ICD-8 — 388

2 out of 7 registries used, show all original rules.

190

4. Check minimum number of events

None

190

5. Include endpoints

None

190

6. Filter based on genotype QC (FinnGen only)

184

Control definitions (FinnGen only)

Control exclude
H8_OTHEREAR

Extra metadata

Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
H91
Name in latin
Surdomutitas non alibi classificata

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 2290 1093 1167
Only index persons 1776 903 873
Unadjusted period prevalence (%)
Whole population 0.03 0.03 0.03
Only index persons 0.03 0.03 0.03
Median age at first event (years)
Whole population 43.90 44.20 43.06
Only index persons 35.92 40.27 31.41

-FinnGen-

Key figures

All Female Male
Number of individuals 184 96 88
Unadjusted period prevalence (%) 0.04 0.03 0.04
Median age at first event (years) 47.92 44.34 51.82

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
190
Matched controls
1900
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
226.2
220.4
108
11
H91.3
ICD-10 Finland
Deaf mutism, not elsewhere classified
+∞
117.2
100
*
3897A
ICD-9 Finland
Deafness, Deaf mutism, not elsewhere classifiable[SURDITAS]
+∞
64.3
58
*
DFF00
NOMESCO Finland
Pure tone audiometry
18.3
48.3
42
29
N07CA01
ATC
betahistine; oral
9.1
31.6
44
61
Z01.1
ICD-10 Finland
Examination of ears and hearing
8.4
29.5
44
66
Z3229
NOMESCO Finland
Other healthcare associate professional
8.2
26.2
39
58
Z97.4
ICD-10 Finland
Presence of external hearing-aid
104.3
25.4
27
*
38801
ICD-8 Finland
Deaf mutism, Congenita
+∞
23.4
22
*
DAX00
NOMESCO Finland
Adjustment or review of hearing aid
260.1
23.2
23
*
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
6.1
23.0
47
97
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
7.6
21.2
33
51
Z46.1
ICD-10 Finland
Fitting and adjustment of hearing aid
26.0
21.1
29
13
H90.5
ICD-10 Finland
Sensorineural hearing loss, unspecified
117.4
20.0
21
*
R5430
NOMESCO Finland
Interpreter's services
222.2
20.0
20
*
H93.1
ICD-10 Finland
Tinnitus
22.2
18.8
27
14
DFF15
NOMESCO Finland
Speech audiometry
49.4
18.7
22
5
R5130
NOMESCO Finland
Repair work or maintenance done on the aid
69.9
17.1
19
*
H91.2
ICD-10 Finland
Sudden idiopathic hearing loss
+∞
16.9
16
*
DAX08
NOMESCO Finland
Fitting of hearing aid
92.9
15.8
17
*
H90.6
ICD-10 Finland
Mixed conductive and sensorineural hearing loss, bilateral
+∞
13.7
13
*
DFE00
NOMESCO Finland
Insertion of cochlear implant
+∞
13.7
13
*
38900
ICD-8 Finland
Other deafness, Deafness, both ears
+∞
13.7
13
*
DFF30
NOMESCO Finland
Loudness discomfort Level (LDL)
150.3
13.6
14
*
UDC00
NOMESCO Finland
Ear microscopy
6.4
13.1
23
40
R5120
NOMESCO Finland
Preparation of an aid
26.5
12.7
17
7
3891A
ICD-9 Finland
Deafness, Sensorineural deafness
+∞
12.6
12
*
H90.4
ICD-10 Finland
Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side
40.4
12.4
15
*
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
4.8
11.8
29
69
DFX00
NOMESCO Finland
Connecting cochlear implant
+∞
11.6
11
*
38809
ICD-8 Finland
Deaf mutism, Unspecified
+∞
10.5
10
*
H90.7
ICD-10 Finland
Mixed conductive and sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side
+∞
9.4
9
*
38800
ICD-8 Finland
Deaf mutism, Acquisita
+∞
9.4
9
*
3897B
ICD-9 Finland
Deafness, Deaf mutism, not elsewhere classifiable[SURDOMUTITAS]
+∞
9.4
9
*
38990
ICD-8 Finland
Other deafness, Partialis uni-sive bilateralis
+∞
9.4
9
*
R5140
NOMESCO Finland
Monitoring the use of the aid
3.6
9.0
32
100
3882A
ICD-9 Finland
Other disorders of ear, Sudden hearing loss, unspecified
+∞
8.4
8
*
R4135
NOMESCO Finland
Rehabilitation for hearing problems
+∞
8.4
8
*
H91.9
ICD-10 Finland
Hearing loss, unspecified
9.1
8.0
16
19
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.8
7.8
46
194
RK520, ,
NOMESCO Finland
46.9
7.8
9
*
RK320, ,
NOMESCO Finland
21.0
7.2
10
5
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
4.5
7.2
18
43
H02
ICPC
Hearing complaint
3.6
6.8
24
74
DC1AD
NOMESCO Finland
Temporalbone CT
23.5
6.7
9
*
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
2.7
6.7
40
169
R42
ICD-10 Finland
Dizziness and giddiness
2.5
6.6
52
252
SPAT1232
SPAT
Communication with help of interpreter or assistant
72.2
6.5
7
*
H90.1
ICD-10 Finland
Conductive hearing loss, unilateral with unrestricted hearing on the contralateral side
72.2
6.5
7
*
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
2.4
6.4
51
248
H81.0
ICD-10 Finland
Ménière disease
11.6
6.4
11
10
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
2.9
6.3
32
124

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
76
413
2.40
7.62
4.4
3.9
—
—
—
0
0
50
232
2.57
6.97
2.1
1.6
1359.66
1181.07
nmol/l
0.58
34
188
55
273
2.43
6.61
1.8
1.7
143902895.63
444.60
pmol/l
0.49
41
237
31
120
2.89
6.08
4.2
4.8
—
—
—
0
0
85
544
2.02
5.23
4.7
3.7
31.32
35.84
ng/l
0.26
68
390
70
434
1.97
4.60
2.2
2.2
—
—
—
0
0
94
648
1.89
4.46
15.0
13.3
1.43
1.25
inr
0.82
24
183
8
9
9.21
4.32
1.8
2.3
—
—
—
0
0
67
422
1.91
4.13
2.3
2.0
154.10
216.25
u/l
0.69
67
399
29
141
2.25
3.55
2.4
1.6
—
—
—
0
0
53
325
1.87
3.47
3.5
1.9
3.37
3.22
mg/l
0.14
43
280
95
697
1.73
3.38
6.7
6.7
1.21
1.21
mmol/l
0.45
78
604
87
634
1.69
3.10
11.7
5.5
1.21
1.21
mmol/l
0.52
73
588
136
1118
1.76
3.08
7.7
7.2
76.41
79.00
u/l
0.44
123
1055
63
422
1.74
3.04
3.3
2.8
—
—
—
0
0
82
591
1.68
3.03
5.5
4.3
35.81
35.51
g/l
0.20
71
564
62
418
1.72
2.91
4.7
3.6
18.13
9.11
mg/mmol
0.86
36
269
21
98
2.28
2.83
2.4
2.8
3.89
3.89
e9/l
0.00
14
78
22
105
2.24
2.82
6.6
3.9
—
—
—
0
0
59
396
1.71
2.80
3.7
3.0
123.93
51.86
mg/l
1.25
33
265
61
416
1.69
2.72
3.8
2.9
6.73
7.53
mmol/l
0.88
49
362
15
61
2.58
2.69
7.1
4.8
—
—
—
0
0
118
959
1.61
2.54
5.6
4.0
—
—
—
0
0
26
141
1.98
2.42
8.5
3.7
—
—
—
0
0
21
106
2.10
2.36
3.6
3.4
—
—
—
0
0
62
439
1.61
2.35
2.6
2.4
53.19
64.77
u/l
0.53
54
413
76
570
1.56
2.24
2.5
1.9
97.09
96.98
pmol/l
0.01
37
291
126
1058
1.57
2.22
4.4
3.8
14.86
14.85
pmol/l
0.01
103
968
162
1452
1.79
2.13
22.1
15.5
139.57
139.73
mmol/l
0.32
154
1411
149
1308
1.64
2.10
5.3
4.5
1.92
1.94
mu/l
0.07
127
1197
162
1456
1.76
2.06
22.2
15.7
4.00
3.97
mmol/l
0.57
155
1414
55
390
1.58
2.04
4.5
4.0
—
—
—
0
0
21
114
1.95
1.96
3.1
4.7
1.38
0.44
%
—
8
39
30
186
1.73
1.86
10.4
6.5
104.33
104.00
mmol/l
0.16
30
186
22
124
1.88
1.85
3.0
4.7
0.56
0.57
%
—
9
48
21
117
1.89
1.83
11.2
7.8
—
—
—
0
0
21
117
1.89
1.83
3.1
4.8
0.00
0.17
%
—
8
41
30
191
1.68
1.70
2.4
1.7
—
—
—
0
0
49
352
1.53
1.70
1.7
1.5
22.69
22.12
nmol/l
0.06
35
300
13
63
2.14
1.64
2.4
2.2
—
—
—
0
0
5
14
3.64
1.62
2.2
1.5
—
—
—
0
0
30
196
1.63
1.55
3.5
2.2
2.47
2.34
g/l
0.49
23
179
73
579
1.42
1.53
4.0
2.5
98.72
116.53
ug/l
0.42
62
534
91
753
1.40
1.49
5.3
6.3
9.19
11.16
umol/l
2.11
81
720
32
215
1.59
1.48
3.5
2.3
12.32
13.78
umol/l
0.55
26
200
7
28
2.56
1.46
5.0
3.6
56.14
59.11
%
—
7
28
7
28
2.56
1.46
4.1
2.8
3.30
4.75
e9/l
—
7
28
164
1517
1.59
1.39
12.3
10.2
25.24
25.81
u/l
0.20
152
1477
146
1324
1.44
1.32
7.1
5.5
40.58
40.08
mmol/mol
0.24
127
1248
18
109
1.72
1.24
3.3
4.9
0.00
0.03
%
—
5
33
81
674
1.35
1.22
5.6
5.7
0.65
0.67
%
0.13
71
631
60
476
1.38
1.22
2.9
3.5
2.33
2.35
mmol/l
0.44
46
431
11
57
1.99
1.19
24.8
4.5
—
—
—
0
0
24
159
1.58
1.19
1.5
2.8
1.57
1.74
%
0.50
19
147
27
185
1.54
1.16
3.9
2.3
21.39
23.24
%
0.30
19
165
17
105
1.68
1.10
1.6
1.4
—
—
—
0
0
28
196
1.50
1.10
1.4
1.4
640.00
591.11
titre
—
9
45
20
130
1.60
1.08
2.4
2.5
3.80
6.31
ug/l
0.56
13
115
46
358
1.38
1.04
6.0
4.0
0.00
0.00
estimate
-0.00
20
121
5
22
2.31
1.04
1.6
4.7
—
—
—
0
0
9
48
1.92
1.02
2.4
1.8
0.18
0.23
g/l
—
9
48
83
710
1.30
0.99
5.6
5.9
24.71
27.71
%
1.65
73
669
81
694
1.29
0.94
5.6
5.7
2.82
2.85
%
0.03
71
653
167
1580
1.47
0.94
26.6
20.1
133.46
135.60
g/l
1.05
161
1556
9
52
1.77
0.94
2.4
1.7
1.01
1.15
g/l
—
9
52
81
697
1.28
0.91
5.7
6.0
8.55
8.51
%
0.04
70
658
119
1077
1.28
0.88
4.5
3.9
13.53
12.99
mm/h
0.15
103
991
8
137
0.57
0.87
1.5
1.4
—
—
—
0
0
81
701
1.27
0.86
5.5
5.7
59.49
57.34
%
0.73
71
663
15
97
1.59
0.84
1.2
1.2
—
—
—
0
0
166
1576
1.42
0.84
26.7
20.0
258.16
247.54
e9/l
1.16
160
1536
89
1000
0.79
0.83
4.4
3.8
—
—
—
0
0
166
1577
1.42
0.82
26.5
20.1
40.00
40.24
%
0.20
150
1499
166
1578
1.41
0.81
26.5
19.9
30.27
30.31
pg
0.09
161
1556
166
1579
1.41
0.80
26.7
20.0
4.43
4.50
e12/l
0.84
158
1534
166
1579
1.41
0.80
26.7
20.0
6.86
6.64
e9/l
0.77
159
1534
166
1579
1.41
0.80
26.6
19.9
91.24
91.20
fl
0.03
161
1558
6
33
1.84
0.79
16.5
2.5
26.27
25.13
mmol/l
—
6
33
0
25
0.00
0.79
0.0
1.1
—
—
—
0
0
79
688
1.25
0.78
7.2
6.2
—
—
—
0
0
0
28
0.00
0.76
0.0
2.4
—
—
—
0
0
78
680
1.25
0.76
5.1
3.7
0.00
0.01
estimate
0.50
22
139
5
24
2.11
0.75
12.8
2.3
5.10
4.98
kpa
—
5
24
5
24
2.11
0.75
1.0
1.2
—
—
—
0
0
5
24
2.11
0.75
12.8
2.3
8.72
8.73
kpa
—
5
24
5
24
2.11
0.75
1.2
1.9
56.80
64.84
%
—
5
24
5
25
2.03
0.73
1.2
2.9
—
—
—
0
0
7
41
1.73
0.70
1.6
1.6
—
—
—
0
0
24
180
1.38
0.69
1.3
1.2
—
—
—
0
0
7
42
1.69
0.69
9.4
13.1
—
—
—
0
0
46
382
1.27
0.67
4.9
3.3
—
—
—
0
0
5
28
1.81
0.66
1.4
1.3
4.09
12.01
u/l
—
5
22
78
690
1.22
0.65
5.3
3.8
0.00
0.00
estimate
-0.00
22
123
85
759
1.22
0.64
5.9
5.9
0.18
0.19
e9/l
0.28
73
673
66
575
1.23
0.63
2.2
2.0
—
—
—
0
0
156
1486
1.28
0.61
19.2
12.0
—
—
—
0
0
8
53
1.53
0.59
1.6
1.6
—
—
—
0
0
22
169
1.34
0.56
1.2
1.2
—
—
—
0
0
76
679
1.20
0.56
6.5
5.1
0.00
0.00
estimate
-0.00
22
128
22
280
0.76
0.55
2.4
2.8
0.83
0.86
ug/l
0.06
12
182
52
451
1.21
0.52
4.0
4.6
1.81
2.37
ug/l
0.40
43
403
36
300
1.25
0.52
2.0
1.8
0.96
1.14
mg/l
0.32
28
229
83
753
1.18
0.50
5.8
5.7
1.69
1.89
e9/l
1.02
73
672
149
1422
1.22
0.50
18.7
13.7
23.36
22.52
mg/l
0.10
125
1126
71
639
1.18
0.47
12.1
9.1
0.00
0.00
e9/l
0.27
62
530
19
148
1.32
0.45
2.2
1.5
—
—
—
0
0
9
130
0.68
0.45
1.6
1.5
—
—
—
0
0
81
741
1.16
0.43
5.9
5.6
0.58
0.57
e9/l
0.22
69
649
81
742
1.16
0.42
5.9
5.6
0.04
0.04
e9/l
0.02
70
650
5
32
1.58
0.42
11.4
2.8
8.72
8.04
kpa
—
5
32
20
159
1.29
0.42
1.4
1.4
—
—
—
0
0
0
15
0.00
0.41
0.0
1.9
—
39.92
—
0
15
22
178
1.27
0.41
2.1
1.5
—
—
—
0
0
0
17
0.00
0.41
0.0
2.9
—
39.38
—
0
8
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
5
35
1.44
0.39
3.6
1.9
—
—
—
0
0
11
80
1.40
0.39
1.1
1.3
—
—
—
0
0
0
19
0.00
0.39
0.0
1.3
—
—
—
0
0
12
89
1.37
0.39
2.0
1.8
—
—
—
0
0
149
1435
1.18
0.37
5.4
4.9
2.61
2.75
mmol/l
1.06
128
1326
12
90
1.36
0.36
1.0
1.2
121.66
156.79
iu/ml
—
7
30
144
1385
1.16
0.36
5.4
4.4
6.01
5.98
mmol/l
0.10
121
1272
27
228
1.21
0.36
2.2
1.9
29.91
29.76
s
0.06
27
222
10
73
1.39
0.35
9.2
7.4
25.67
25.11
mmol/l
—
10
73
6
44
1.38
0.34
1.7
1.3
—
—
titre
—
0
0
32
367
0.85
0.33
6.0
7.1
—
—
—
0
0
40
450
0.86
0.33
4.8
3.0
39.64
27.06
e6/l
0.18
29
340
31
271
1.17
0.29
1.5
1.4
2.33
2.56
g/l
0.22
17
168
9
73
1.24
0.26
5.2
3.7
—
—
—
0
0
28
316
0.87
0.24
5.5
3.7
—
—
—
0
0
32
285
1.15
0.24
1.5
1.2
1.13
1.65
u/ml
—
6
80
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
168.48
—
0
12
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
9
115
0.77
0.20
2.2
2.3
68.01
67.10
g/l
—
9
109
144
1405
1.10
0.19
5.1
4.4
4.51
4.66
mmol/l
0.88
123
1314
6
52
1.16
0.19
1.7
1.2
—
—
—
0
0
6
53
1.14
0.19
2.3
2.7
—
—
—
0
0
10
83
1.22
0.16
3.5
3.3
4.35
4.50
pmol/l
—
10
72
88
847
1.07
0.15
8.3
9.6
4.14
3.97
e9/l
0.36
76
748
32
298
1.09
0.12
4.0
2.5
5.59
3.91
e6/l
0.49
27
267
142
1395
1.07
0.12
5.3
4.3
1.48
1.47
mmol/l
0.06
122
1292
26
240
1.10
0.12
1.2
1.2
3.82
14.05
u/ml
0.97
12
100
49
514
0.94
0.11
4.9
3.6
120.85
45.78
e6/l
0.47
33
360
47
448
1.07
0.10
5.2
3.7
7.40
7.40
ph
0.18
11
85
11
96
1.15
0.10
1.8
1.8
1.10
1.61
g/l
0.73
11
88
29
271
1.08
0.10
3.0
3.3
1105.00
133.80
ng/l
0.45
22
211
38
401
0.93
0.10
4.9
2.9
0.45
0.40
e6/l
0.06
28
292
37
350
1.07
0.10
1.2
1.4
—
—
—
0
0
10
87
1.16
0.09
2.0
3.9
—
—
—
0
0
10
87
1.16
0.09
3.4
6.8
25.06
24.31
mmol/l
—
10
81
5
47
1.07
0.09
1.2
1.1
—
—
—
0
0
6
56
1.07
0.09
1.0
1.1
—
—
—
0
0
6
57
1.05
0.08
1.0
1.2
—
—
—
0
0
15
164
0.91
0.08
1.8
4.7
3.05
48.22
ug/l
—
8
143
37
353
1.06
0.08
1.9
2.9
348.50
9730.82
umol/l
2.20
28
315
137
1352
1.05
0.07
4.7
3.9
1.28
1.28
mmol/l
0.03
116
1243
26
275
0.94
0.07
2.7
3.0
2.44
2.45
mmol/l
0.15
20
246
30
287
1.05
0.05
4.6
2.9
486.88
553.30
mosm/kgh2o
1.11
24
243
23
240
0.95
0.03
1.2
1.3
47.98
41.77
iu/ml
—
9
94
38
387
0.98
0.01
1.8
1.7
1.47
1.41
mmol/l
0.15
30
328
11
106
1.04
0.00
1.5
2.7
—
—
—
0
0
11
114
0.96
0.00
1.7
2.6
11.82
10.55
g/l
0.62
11
106
13
134
0.97
0.00
1.5
1.6
—
—
—
0
0
14
144
0.97
0.00
1.3
1.4
—
—
—
0
0
11
113
0.97
0.00
1.2
1.4
—
—
—
0
0
15
147
1.02
0.00
1.3
1.3
—
—
—
0
0
39
395
0.98
0.00
4.1
2.8
—
—
—
0
0
23
235
0.98
0.00
3.7
2.8
1.88
2.44
e6/l
0.27
13
126
10
95
1.06
0.00
1.1
1.4
—
—
—
0
0
21
212
0.99
0.00
2.4
1.7
—
—
—
0
0
0
8
0.00
0.00
0.0
1.1
—
321.75
—
0
8
0
8
0.00
0.00
0.0
2.6
—
—
—
0
0
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
-0.00
0.0
16.0
—
898.22
—
0
9
0
6
0.00
-0.00
0.0
1.7
—
—
—
0
0
9
91
0.99
-0.00
1.1
1.3
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.4
—
1.19
—
0
5
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
53
530
1.00
-0.00
3.6
2.8
—
—
—
0
0
0
7
0.00
-0.00
0.0
9.4
—
0.60
—
0
7
0
9
0.00
-0.00
0.0
19.1
—
1338.56
—
0
9
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
9
97
0.92
-0.00
1.7
2.2
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.2
—
7.24
—
0
9

Mortality – FinRegistry

↥

Association

Association between endpoint H8_HL_DEAFMUT and mortality.

Females

Parameter HR [95% CI] p-value
H8_HL_DEAFMUT 0.972 [0.76, 1.25] 0.828
Birth year 0.994 [0.99, 1.0] 0.144

During the follow-up period (1.1.1998 — 31.12.2019), 84 out of 364 females with H8_HL_DEAFMUT died.

Males

Parameter HR [95% CI] p-value
H8_HL_DEAFMUT 1.274 [0.94, 1.72] 0.117
Birth year 0.988 [0.98, 1.0] 0.011

During the follow-up period (1.1.1998 — 31.12.2019), 94 out of 329 males with H8_HL_DEAFMUT died.

Mortality risk

Mortality risk for people of age

years, who have H8_HL_DEAFMUT.

N-year risk Females Males
1 0.062% 0.198%
5 0.475% 1.537%
10 1.164% 3.742%
15 2.581% 6.891%
20 4.467% 12.099%

Relationships between endpoints

↥

Index endpoint: H8_HL_DEAFMUT – Deaf mutism, not elsewhere classified

GWS hits: 2

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data